Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes

Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes

Abstract Background Sodium-glucose cotransporter 2 (SGLT2) inhibition reduces cardiovascular events in type 2 diabetes (T2DM) and is associated with a reduction in left ventricular (LV) mass index. However, the impact on right ventricular (RV) remodeling is unknown. Accordingly, the objective of thi...

Full description

Bibliographic Details
Main Authors: Bradley Sarak, Subodh Verma, C. David Mazer, Hwee Teoh, Adrian Quan, Richard E. Gilbert, Shaun G. Goodman, Karan Bami, Otávio R. Coelho-Filho, Vineeta Ahooja, Djeven P. Deva, Vinay Garg, Sumeet Gandhi, Kim A. Connelly, Andrew T. Yan
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Cardiovascular Diabetology
Subjects:
Type 2 diabetes
Right ventricle
Sodium-glucose transporter 2 inhibition
Online Access:https://doi.org/10.1186/s12933-021-01390-8

Internet

https://doi.org/10.1186/s12933-021-01390-8

Similar Items